Ident. | Authors (with country if any) | Title |
---|
000591 (2014) |
Jung Han Yoon [Corée du Sud] ; Jin Soo Lee ; Seok Woo Yong ; Ji Man Hong ; Phil Hyu Lee | Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: flow-mediated dilation study. |
000A78 (2013) |
David J. Graham [États-Unis] ; James R. Williams ; Ya-Hui Hsueh ; Katlyn Calia ; Mark Levenson ; Simone P. Pinheiro ; Thomas E. Macurdy ; David Shih ; Chris Worrall ; Jeffrey A. Kelman | Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone. |
001963 (2010) |
Maria Nord [Suède] ; Peter Zsigmond [Suède] ; Anita Kullman [Suède] ; Kerstin Rstrand [Suède] ; Nil Dizdar [Suède] | The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF |
001F93 (2009) |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
002065 (2009) |
Davide Manca [Italie] ; Giovanni Cossu [Italie] ; Daniela Murgia [Italie] ; Andrea Molari [Italie] ; Paola Ferrigno [Italie] ; Emanuele Marcia [Italie] ; Maurizio Melis [Italie] | Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy |
002105 (2009) |
Victor S. C. Fung [Australie] ; Lilie Herawati [Australie] ; Ying Wan [États-Unis] | Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone |
002136 (2009) |
Peter A. Lewitt [États-Unis] ; Danna Jennings [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Adrian L. Rabinowicz [États-Unis] ; James Wang [États-Unis] ; Maria Guarnieri [États-Unis] ; Jean P. Hubble [États-Unis] ; Harold Murck [États-Unis] | Pharmacokinetic‐pharmacodynamic crossover comparison of two levodopa extension strategies |
002342 (2009) |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease |
002869 (2008) |
Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Oliver Goetze [Allemagne, Suisse] ; Christoph Erdmann [Allemagne] | Entacapone improves absorption of a coadministered salt in patients with Parkinson's disease |
002B83 (2007) |
Jonas Lindh [Suède] | Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine |
002C71 (2007) |
Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon] | Placebo‐controlled, double‐blind dose‐finding study of entacapone in fluctuating parkinsonian patients |
002E59 (2007) |
| Entacapone to tolcapone switch: Multicenter double‐blind, randomized, active‐controlled trial in advanced Parkinson's disease |
002E65 (2007) |
Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer [Allemagne] ; Ariel Gordin | Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing‐off |
003379 (2006) |
Thomas Müller [Allemagne] ; Christoph Erdmann [Allemagne] ; Siegfried Muhlack [Allemagne] ; Dirk Bremen [Allemagne] ; Horst Przuntek [Allemagne] ; Dirk Woitalla [Allemagne] | Inhibition of catechol‐O‐methyltransferase contributes to more stable levodopa plasma levels |
003450 (2006) |
Alexei Korchounov [Allemagne, Égypte] ; Gregory Bogomazov [Russie] | Employment, medical absenteeism, and disability perception in Parkinson's disease: A pilot double‐blind, randomized, placebo‐controlled study of entacapone adjunctive therapy |
003526 (2006) |
Concepci Marin [Espagne] ; Esther Aguilar [Espagne] ; José A. Obeso [Espagne] | Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats |
003742 (2005) |
Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
003837 (2005) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates |
003939 (2005) |
Paolo Lamberti [Italie] ; Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Elio Armenise [Italie] ; Angela Fraddosio [Italie] ; Michele De Mari [Italie] ; Paolo Livrea [Italie] | Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients |
003B37 (2004) |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
004108 (2003) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure |